Correspondence:
The clinical manifestations of COVID-19 range from mild upper respiratory tract illnesses to progressive severe pneumonia, acute respiratory distress syndrome, multi-organ failure, and death. Measures to control the impact of the virus have affected job security, social contact and challenged health services, medical practices and policies. The health service has been radically mobilised to respond to the acute needs of patients infected with the virus at the same time as delivering scaled-back non-COVID-19 healthcare. In many surgical specialties, the management of perioperative patients has changed, with greater focus on remote triage through virtual consultations. However, pre-operative evaluation of surgical candidates still must happen, in person, at the clinic. One important aspect of pre-operative evaluation prior to thoracic surgery is pulmonary function testing (PFT), traditionally measured by conventional spirometry.
Anzeige
Understandably, concern has been raised that PFT represents a potential avenue for increased COVID-19 transmission due to increased viral dissemination. The healthcare sector is calling upon novel technology to replace PFT with a non-aerosol-generating alternative.
Structured Light Plethysmography (SLP), delivered by PneumaCare Thora-3DI™ systems, has been proposed as a novel, non-contact, non-invasive method of assessing lung function. SLP offers real-time regional respiratory function via movement of the chest wall. This detailed information is then translated into quantifiable pulmonary function outputs. SLP data has been used to optimize non-invasive ventilatory settings. The field has used SLP to successfully differentiate between the breathing patterns of healthy patients and those with COPD by mapping the thoracoabdominal displacement rate and accurately estimating inspiratory and expiratory flow [1]. The ability to continuously measure these parameters may contribute to the safe weaning of patients from ventilatory support. Additionally, we believe that SLP technology will allow clinicians to obtain measurements of breathing patterns that are closer to ecological conditions than those derived from spirometry measurements.
Our centre is currently trialling SLP in the work-up of pre-operative cardiothoracic patients. We have so far enrolled 20 patients in our pilot study comparing the feasibility of SLP measurements as parameters indicative for lung function. Our initial results demonstrated a correlation between the IE50SLP (inspiratory to expiratory flow at 50% tidal volume) measurement and the forced expiratory volume in the first second of expiration (p = 0.021, r = − 0.62). We feel it is intuitive to use and, therefore, does not require trained technicians, resulting in increased patient throughput and lower costs to the department. Care efficiency also improves as the time-per-appointment is reduced, benefitting patient wait times and increasing satisfaction. Importantly, SLP offers clinicians continuous measurement of mechanical chest wall displacement, a surrogate marker for fatigability and neuromuscular strength.
For the aforementioned reasons, we feel that SLP is a viable alternative to spirometry, especially in the current pandemic. Spirometry remains the gold-standard PFT, however, and the field would certainly benefit from studies evaluating the sensitivity, specificity and clinical validity of SLP in impairment detection, against gold-standard PFT.
Anzeige
Acknowledgements
Not applicable.
Declarations
Ethics approval and consent to participate
Ethics approval was waived.
Consent for publication
Not applicable.
Competing interests
The authors declare they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.